RESUMO
Previous case series have described the safety and efficacy of different stent models for stent-assisted aneurysm coiling (SAC), but comparative analyses of procedural results are limited. This study investigates the procedural outcome and safety of three different stent models (Atlas™, LEO+™ (Baby) and Enterprise™) in the setting of elective SAC treated at a tertiary neuro-endovascular center. We retrospectively reviewed all consecutively treated patients that received endovascular SAC for intracranial aneurysms between 1 July 2013 and 31 March 2020, excluding all emergency angiographies for acute subarachnoid hemorrhage. The primary procedural outcome was the occlusion rate evaluated with the Raymond-Roy occlusion classification (RROC) assessed on digital subtraction angiography (DSA) at 6- and 12-month follow-up. Safety assessment included periprocedural adverse events (i.e., symptomatic ischemic complications, symptomatic intracerebral hemorrhage, iatrogenic perforation, dissection, or aneurysm rupture and in-stent thrombosis) and in-house mortality. Uni- and multivariable logistic regression analyses were performed to identify patient baseline and aneurysm characteristics that were associated with complete aneurysm obliteration at follow-up. A total of 156 patients undergoing endovascular treatment via SAC met the inclusion criteria. The median age was 62 years (IQR, 55-71), and 73.7% (115) of patients were female. At first follow-up (6-month) and last available follow-up (12 and 18 months), complete aneurysm occlusion was observed in 78.3% (90) and 76.9% (102) of patients, respectively. There were no differences regarding the occlusion rates stratified by stent model. Multivariable logistic analysis revealed increasing dome/neck ratio (adjusted odds ratio (aOR), 0.26.; 95% CI, 0.11-0.64; p = 0.003), increasing neck size (aOR, 0.70; 95% CI, 0.51-0.96; p = 0.027), and female sex (aOR, 4.37; 95% CI, 1.68-11.36; p = 0.002) as independently associated with treatment success. This study showed comparable rates of complete long-term aneurysm obliteration and safety following SAC for intracranial aneurysm with three different stent-models highlighting the procedural feasibility of this treatment strategy with currently available stent-models. Increased neck size and a higher dome/neck ratio were independent variables associated with less frequent complete aneurysm obliteration.
RESUMO
Neurovascular coupling describes the cascade between neuronal activity and subsequent Blood-Oxygenation-Level-Dependent (BOLD) signal increase. Based on this premise, the correlation of this BOLD signal increase with a particular task, such as finger-tapping, is used to map neuronal activation. This signal increase may be dampened in brain areas exhibiting impaired cerebrovascular reactivity (BOLD-CVR), leading to false negative activation. Blood-oxygenation-level-dependent (BOLD) cerebrovascular reactivity (CVR) has also been used to optimize task evoked BOLD signal changes. To measure BOLD-CVR, controlled BOLD-CVR studies have commonly been performed using a preset isocapnic carbon dioxide (CO2; ~40â¯mmHg) baseline, independent of subjects' resting CO2. This arbitrary baseline, however, may influence BOLD-CVR measurements. We therefore performed BOLD-CVR, as well as BOLD fMRI during a controlled bilateral finger-tapping task in two groups of ten subjects: group A at subject's resting CO2 and group B at a preset isocapnic CO2 baseline (40â¯mmHg). Whole brain BOLD-CVR was significantly decreased for group B (group A 0.26 (SD 0.05) vs group B 0.16 (SD 0.05), pâ¯<â¯0.001). For the predefined hand area in the precentral cortex, BOLD-CVR and BOLD fMRI signal changes were significantly lower for group B (group A 0.20 (SD 0.04) vs group B 0.13 (SD 0.05), pâ¯<â¯0.01; 1.19 (SD 0.31) vs 0.62 (SD 0.37), pâ¯<â¯0.01).CO2 levels significantly influence both BOLD-CVR and BOLD fMRI measurements. Hence, for an accurate interpretation, baseline CO2 levels and BOLD CVR should be considered complementary to task evoked BOLD fMRI.